Sebia – high-resolution haemoglobin screening method
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Haemoglobinopathies, such as sickle cell disease and alpha/beta thalassemia major, are prevalent genetic disorders that affect the protein part of haemoglobin (Hb). With a growing global disease burden, accurate and rapid diagnosis of these conditions is crucial for optimal management and genetic counseling.
Sebia*, a leading provider of diagnostic solutions, offers a revolutionary high-resolution haemoglobin screening method that is transforming the field of genetic testing.
Sebia’s Hb screening methods key features
- Fully automated haemoglobin testing
Load-and-go workflow improves efficiency and reduces hands-on-time. - High-resolution
High-resolution separation indicates patient variant status with color coded profiles for quick result validation. - Accurate and precise
Approved for quantitation of common Hb variants, Hb F and Hb A2 for thalassemia screening. - On-board identification assistance
Simplified presumptive identification using zones with the built-in Hb variant library and x-migration positions. - Easy-to-use
Whole-blood, capped tubes with automated on-board sample mixing eliminates.
The Capillary Electrophoresis technology provides a fully automated workflow, reducing hands-on time and improving efficiency in laboratories. The high-resolution separation allows for quick and accurate identification of patient variant status, with color-coded profiles for easy result validation.
The system is approved for quantitation of common Hb variants, Hb F, and Hb A2, enabling effective thalassemia screening. Additionally, the built-in Hb variant library and on-board identification assistance simplify presumptive identification.
Easy detection of common and rare haemoglobin variants
Learn more about Sebia’s Hb screening method solution
Sebia’s haemoglobin screening method offers numerous benefits to laboratories and clinicians. The easy-to-use system eliminates the need for manual processing, while the automated on-board sample mixing ensures consistent and reliable results. With Sebia’s broad range of Capillary instruments, laboratories can find a tailored solution to meet their specific workload requirements.
By providing accurate and rapid diagnosis, this innovative technology enables optimal management of affected individuals and offers valuable genetic counseling and reproductive options for carriers.
* Abacus dx is the exclusive distributor for Sebia in Australia.
